SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-083083
Filing Date
2023-07-21
Accepted
2023-07-21 16:39:46
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 tm2321698d1_424b5.htm 424B5 507123
2 GRAPHIC tm2321698d1_424b5img001.jpg GRAPHIC 20851
3 GRAPHIC tm2321698d1_424b5img002.jpg GRAPHIC 20049
4 GRAPHIC tm2133457d1_s3aimg001.jpg GRAPHIC 4343
5 GRAPHIC tm2321698d1_424b5img003.jpg GRAPHIC 36872
6 GRAPHIC tm2321698d1_424b5img004.jpg GRAPHIC 4707
  Complete submission text file 0001104659-23-083083.txt   628635
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254996 | Film No.: 231102953
SIC: 2834 Pharmaceutical Preparations